These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15850921)

  • 21. Minimizing local recurrence after breast conserving therapy using intraoperative shaved margins to determine pathologic tumor clearance.
    Camp ER; McAuliffe PF; Gilroy JS; Morris CG; Lind DS; Mendenhall NP; Copeland EM
    J Am Coll Surg; 2005 Dec; 201(6):855-61. PubMed ID: 16310688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Audit of local recurrence rates following 'ultra'-conservative surgery for invasive breast cancer--a boost to the breast?
    Cota AM; Humphreys S; Schofield J; Sever A; Jones S; Pickering D; Jones PA
    Breast; 2005 Jun; 14(3):224-9. PubMed ID: 15927831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical outcome of breast conservation therapy for breast cancer in Hong Kong: prognostic impact of ipsilateral breast tumor recurrence and 2005 St. Gallen risk categories.
    Yau TK; Soong IS; Chan K; Chan M; Cheung P; Lau HW; Chang AT; Lee AW
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):667-72. PubMed ID: 17379441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biopsy findings after breast conservation therapy for early-stage invasive breast cancer.
    Vapiwala N; Starzyk J; Harris EE; Tchou JC; Boraas MC; Czerniecki BJ; Rosato EF; Orel SG; Solin LJ
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):490-7. PubMed ID: 17544594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conservative surgery in patients with multifocal/multicentric breast cancer.
    Gentilini O; Botteri E; Rotmensz N; Da Lima L; Caliskan M; Garcia-Etienne CA; Sosnovskikh I; Intra M; Mazzarol G; Musmeci S; Veronesi P; Galimberti V; Luini A; Viale G; Goldhirsch A; Veronesi U
    Breast Cancer Res Treat; 2009 Feb; 113(3):577-83. PubMed ID: 18330695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiotherapy omission after breast-conserving surgery is associated with reduced breast cancer-specific survival in elderly women with breast cancer.
    Truong PT; Bernstein V; Lesperance M; Speers CH; Olivotto IA
    Am J Surg; 2006 Jun; 191(6):749-55. PubMed ID: 16720143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome analysis in "high-risk" versus "low-risk" patients eligible for national surgical adjuvant breast and bowel B-39/radiation therapy oncology group 0413 trial: five-year results.
    Patel RR; Christensen ME; Hodge CW; Adkison JB; Das RK
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):970-3. PubMed ID: 18313521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors predicting in-breast tumor recurrence after breast-conserving surgery.
    Mechera R; Viehl CT; Oertli D
    Breast Cancer Res Treat; 2009 Jul; 116(1):171-7. PubMed ID: 18815880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional nodal recurrence after breast conservation treatment with radiotherapy for women with early-stage breast carcinoma.
    Lukens JN; Vapiwala N; Hwang WT; Solin LJ
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1475-81. PubMed ID: 19004570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger.
    Floyd SR; Buchholz TA; Haffty BG; Goldberg S; Niemierko A; Raad RA; Oswald MJ; Sullivan T; Strom EA; Powell SN; Katz A; Taghian AG
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):358-64. PubMed ID: 16887288
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up.
    Antonucci JV; Wallace M; Goldstein NS; Kestin L; Chen P; Benitez P; Dekhne N; Martinez A; Vicini F
    Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):447-52. PubMed ID: 19058921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ductal carcinoma in situ of the breast in Israeli women treated by breast-conserving surgery followed by radiation therapy.
    Jiveliouk I; Corn B; Inbar M; Merimsky O
    Oncology; 2009; 76(1):30-5. PubMed ID: 19033713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local control in 118 consecutive high-risk breast cancer patients treated with breast-conserving therapy.
    Vordermark D; Lackenbauer A; Wulf J; Guckenberger M; Flentje M
    Oncol Rep; 2007 Nov; 18(5):1335-9. PubMed ID: 17914594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
    Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
    Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
    McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of the time between surgery and radiotherapy on local recurrence in patients with lymph node-positive, early-stage, invasive breast carcinoma undergoing breast-conserving surgery: results of the French Adjuvant Study Group.
    Benchalal M; Le Prisé E; de Lafontan B; Berton-Rigaud D; Belkacemi Y; Romestaing P; Peignaux K; Courdi A; Monnier A; Montcuquet P; Goudier MJ; Marchal C; Chollet P; Abadie-Lacourtoisie S; Datchary J; Veyret C; Kerbrat P
    Cancer; 2005 Jul; 104(2):240-50. PubMed ID: 15948160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loco regional failure pattern after lumpectomy and breast irradiation in 4,185 patients with T1 and T2 breast cancer. Implications for nodal irradiation.
    Livi L; Paiar F; Simontacchi G; Barca R; Detti B; Fondelli S; Bastiani P; Santini R; Scotti V; Bianchi S; Cataliotti L; Mungai V; Biti G
    Acta Oncol; 2006; 45(5):564-70. PubMed ID: 16864170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety and feasibility of breast conserving therapy in Indian women: two decades of experience at Tata Memorial Hospital.
    Dinshaw KA; Sarin R; Budrukkar AN; Shrivastava SK; Deshpande DD; Chinoy RF; Badwe R; Hawaldar R
    J Surg Oncol; 2006 Aug; 94(2):105-13. PubMed ID: 16847919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial.
    Poortmans PM; Collette L; Bartelink H; Struikmans H; Van den Bogaert WF; Fourquet A; Jager JJ; Hoogenraad W; Müller RP; Dubois JB; Bolla M; Van Der Hulst M; Wárlám-Rodenhuis CC; Pierart M; Horiot JC;
    Cancer Radiother; 2008 Nov; 12(6-7):565-70. PubMed ID: 18760649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.